Evercore Wealth Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-3,572
Closed -$287K 1078
2016
Q4
$287K Buy
3,572
+1,931
+118% +$153K 0.01% 315
2016
Q3
$131K Sell
1,641
-59
-3% -$4.76K 0.01% 442
2016
Q2
$132K Buy
1,700
+149
+10% +$10.6K 0.01% 422
2016
Q1
$85K Sell
1,551
-54
-3% -$2.94K ﹤0.01% 484
2015
Q4
$99K Buy
1,605
+54
+3% +$3.41K ﹤0.01% 476
2015
Q3
$97K Sell
1,551
-1,516
-49% -$108K ﹤0.01% 490
2015
Q2
$223K Buy
3,067
+1,278
+71% +$92.3K 0.01% 400
2015
Q1
$118K Sell
1,789
-28
-2% -$1.86K 0.01% 508
2014
Q4
$119K Sell
1,817
-172
-9% -$11.1K 0.01% 434
2014
Q3
$119K Buy
1,989
+232
+13% +$15.2K 0.01% 486
2014
Q2
$122K Buy
1,757
+319
+22% +$20.7K 0.01% 479
2014
Q1
$94K Buy
1,438
+238
+20% +$15.5K 0.01% 497
2013
Q4
$74K Hold
1,200
﹤0.01% 503
2013
Q3
$64K Hold
1,200
﹤0.01% 542
2013
Q2
$55K Buy
+1,200
New +$52K ﹤0.01% 555

Other funds holding STJ

Evercore Wealth Management's STJ Position: Q1 2017 in Review

Evercore Wealth Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 3,572 shares — an estimated $287K sold.

Evercore Wealth Management first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $287K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Evercore Wealth Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Evercore Wealth Management sold 3,572 St Jude Medical shares in Q1 2017, an estimated $287K.
  • Evercore Wealth Management first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Evercore Wealth Management's St Jude Medical position peaked at $287K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Evercore Wealth Management's 13F filing for Q1 2017, filed 15 May 2017.